New-onset diabetes after transplantation: Results from a double-blind early corticosteroid withdrawal trial

American Journal of Transplantation

Volumn 15, Issue 7, 2015, Pages 1982-1990

  Pirsch, J D ^a   Henning, A K ^b   First, M R ^c   Fitzsimmons, W ^c   Gaber, A O ^d,e   Reisfield, R ^c   Shihab, F ^f   Woodle, E S ^g  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b EMMES CORPORATION   (United States)

^c ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Clinical research; diabetes: new onset; kidney transplantation; minimization; nephrology; posttransplant; practice; withdrawal

Indexed keywords

ANTIDIABETIC AGENT; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE; AMERICAN INDIAN; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; CHILD; CHRONIC DRUG ADMINISTRATION; COLD ISCHEMIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DIET RESTRICTION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; HISPANIC; HLA MATCHING; HUMAN; INSULIN TREATMENT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES AFTER TRANSPLANTATION; ORGAN DONOR; PACIFIC ISLANDER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RACE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT WITHDRAWAL; ADVERSE EFFECTS; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MIDDLE AGED; ONSET AGE; PATHOLOGY; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; DIABETES MELLITUS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDNISONE; PROGNOSIS; RISK FACTORS; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 84931566091     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13247     Document Type: Article

References (30)

1. Davidson J, Wilkinson A, Dantal J, et al., New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an International Expert Panel Meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003; 75 (10 Suppl): S3-S24.
2. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ., Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185.
3. Pham PT, Pham PC, Lipshutz GS, Wilkinson AH., New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am 2007; 36: 873-890; vii.
4. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC., Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002; 13: 1374-1380.
5. Hjelmesaeth J, Hartmann A, Kofstad J, et al., Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979-983.
6. Neidlinger N, Singh N, Klein C, et al., Incidence of and risk factors for posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant 2010; 10: 398-406.
7. Heisel O, Heisel R, Balshaw R, Keown P., New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004; 4: 583-595.
8. Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC., Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev 2005; 4: CD003961.
9. Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA., Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 1991; 51: 374-377.
10. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrom J, Fauchald P., Tapering off prednisolone and cyclosporin the first year after renal transplantation: The effect on glucose tolerance. Nephrol Dial Transplant 2001; 16: 829-835.
11. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS., A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977-983.
12. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007 [cited 21 Jan 2010]. Available from: http://www.ustransplant.org/annual-reports/current/.
13. Woodle ES, First MR, Pirsch J, et al., A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248: 564-577.
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl 1): S62-S69.
15. American Diabetes Association. Standards of Medical Care in Diabetes-2013. Diabetes Care 2013; 36 (Suppl 1): S11-S66.
16. Pelletier RP, Akin B, Ferguson RM., Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine. Clin Transplant 2006; 20: 10-18.
17. Vincenti F, Schena FP, Paraskevas S, et al., A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008; 8: 307-316.
18. Rostaing L, Cantarovich D, Mourad G, et al., Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005; 79: 807-814.
19. Kramer BK, Klinger M, Wlodarczyk Z, et al., Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: One year observational results. Clin Transplant 2010; 24: E1-E9.
20. Knight SR, Morris PJ., Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 2010; 89: 1-14.
21. First MR, Dhadda S, Croy R, Holman J, Fitzsimmons E., New-onset diabetes after transplantation (NODAT): An evaluation of definitions in clinical trials. Transplantation 2013; 96: 58-64.
22. Yates CJ, Fourlanos S, Hjelmesæth J, Colman PG, Cohney SJ., New-onset diabetes after kidney transplantation-Changes and challenges. Am J Transplant 2012; 12: 820-828.
23. Demirci MS, Toz H, Yilmaz F, et al., Risk factors and consequences of post-transplant diabetes mellitus. Clin Transplant 2010; 24: E170-E177.
24. Hjelmesaeth J, Hartmann A, Leivestad T, et al., The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588-595.
25. Sharif A, Hecking M, de Vries APJ, et al., Proceedings from an international consensus meeting on posttransplant diabetes mellitus: Recommendations and future directions. Am J Transplant 2014; 14: 1992-2000.
26. Pascual J, Zamora J, Galeano C, Royuela A, Quereda C., Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009; 1: CD005632.
27. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC., Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 1992; 53: 563-569.
28. van Hooff JP, Christiaans MH, van Duijnhoven EM., Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005; 79: 1465-1469.
29. Boots JM, van Duijnhoven EM, Christiaans MH, Wolffenbuttel BH, van Hooff JP., Glucose metabolism in renal transplant recipients on tacrolimus: The effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002; 13: 221-227.
30. Midtvedt K, Hjelmesaeth J, Hartmann A, et al., Insulin resistance after renal transplantation: The effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004; 15: 3233-3239.